Evidence map›Paper›PMID 33191478›Full record

ArticleMolecular biology reports2020

The effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell line.

Ozge Balpinar Nalci, Hayrunnisa Nadaroglu, Sidika Genc, Ahmet Hacimuftuoglu, Azize Alayli

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuroprotective Effect of Solid Lipid Nanoparticles Loaded withNanomaterials (Basel, Switzerland) · 2024
    Article
  4. Article
  5. FePharmaceutics · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ozge Balpinar NalciDepartment of Medical Pharmacology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Hayrunnisa NadarogluDepartment of Food Technology, Erzurum Vocational College, Ataturk University, 25240, Erzurum, Turkey. hnisa25@atauni.edu.tr.ORCID http://orcid.org/0000-0002-0536-4212
Sidika GencDepartment of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Ahmet HacimuftuogluDepartment of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Turkey. ahmeth@atauni.edu.tr.
Azize AlayliDepartment of Nursing, Faculty of Health Sciences, Sakarya University of Applied Sciences, 54187, Sakarya, Turkey.
Atatürk University · TROndokuz Mayıs University · TRSakarya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnesium sulfide nanoparticles (MgS NPs) is a nanomaterial that has an important place in diagnosis, treatment, diagnosis, and drug delivery systems. Neuroblastoma, a type of brain cancer, is an extremely difficult cancer to treat with today's treatment options. This study was carried out to determine the cytotoxic, oxidant, and antioxidant effects on the neuroblastoma cancer line (SH-SY5Y cell line) along with the green synthesis and characterization of MgS NPs structures. MgS NPs were synthesized by green synthesis using Na

Indexed as

Antineoplastic AgentsCisplatinMagnesium SulfateMetal NanoparticlesAntioxidantsApoptosisBrain NeoplasmsCell Line, TumorCell SurvivalGreen Chemistry TechnologyHumansNeuroblastomaPomegranateAntineoplastic AgentsAntioxidantsCisplatinMagnesium SulfateBio-conjugateCisplatinMgS NanoparticlesSH-SY5Y neuroblastoma cell lines

Identifiers

PMID33191478
OpenAlexW3101229872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.